Healthcare provider profile · identity verified

Garrett H. Peard, MD

Internal Medicine · MEDFORD, OR · NPI 1124025580

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	824	230
Lisinopril	Lisinopril	449	123
Levothyroxine Sodium	Levothyroxine Sodium	437	115
Amlodipine Besylate	Amlodipine Besylate	401	106
Losartan Potassium	Losartan Potassium	392	94
Omeprazole	Omeprazole	327	94
Metoprolol Succinate	Metoprolol Succinate	325	93
Tamsulosin Hcl	Tamsulosin Hcl	256	75
Gabapentin	Gabapentin	201	57
Rosuvastatin Calcium	Rosuvastatin Calcium	189	60
Potassium Chloride	Potassium Chloride	187	49
Trazodone Hcl	Trazodone Hcl	177	46
Simvastatin	Simvastatin	171	48
Metformin Hcl	Metformin Hcl	155	43
Metformin Hcl Er	Metformin Hcl	147	41
Pravastatin Sodium	Pravastatin Sodium	146	36
Escitalopram Oxalate	Escitalopram Oxalate	135	37
Eliquis	Apixaban	131	35
Pantoprazole Sodium	Pantoprazole Sodium	131	36
Hydrochlorothiazide	Hydrochlorothiazide	130	34
Furosemide	Furosemide	121	34
Xarelto	Rivaroxaban	121	31
Celecoxib	Celecoxib	119	40
Irbesartan	Irbesartan	117	34
Allopurinol	Allopurinol	113	31
Alendronate Sodium	Alendronate Sodium	109	32
Metoprolol Tartrate	Metoprolol Tartrate	101	25
Sertraline Hcl	Sertraline Hcl	100	28
Carvedilol	Carvedilol	97	27
Tramadol Hcl	Tramadol Hcl	96	20
Zolpidem Tartrate	Zolpidem Tartrate	96	31
Duloxetine Hcl	Duloxetine Hcl	93	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	20
Spironolactone	Spironolactone	90	23
Montelukast Sodium	Montelukast Sodium	86	28
Albuterol Sulfate Hfa	Albuterol Sulfate	82	38
Citalopram Hbr	Citalopram Hydrobromide	77	15
Clopidogrel	Clopidogrel Bisulfate	76	19
Bupropion Xl	Bupropion Hcl	75	16
Oxycodone Hcl	Oxycodone Hcl	65	17
Synthroid	Levothyroxine Sodium	65	20
Warfarin Sodium	Warfarin Sodium	65	suppressed
Alprazolam	Alprazolam	64	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	18
Atenolol	Atenolol	61	17
Fluoxetine Hcl	Fluoxetine Hcl	61	15
Donepezil Hcl	Donepezil Hcl	60	15
Finasteride	Finasteride	58	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	57	20
Ezetimibe	Ezetimibe	56	17
Chlorthalidone	Chlorthalidone	55	19
Estradiol	Estradiol	53	16
Fluticasone Propionate	Fluticasone Propionate	51	20
Glimepiride	Glimepiride	50	14
Meloxicam	Meloxicam	48	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	14
Pregabalin	Pregabalin	43	12
Hydralazine Hcl	Hydralazine Hcl	42	suppressed
Prednisone	Prednisone	41	30
Venlafaxine Hcl Er	Venlafaxine Hcl	41	11
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Famotidine	Famotidine	39	11
Lorazepam	Lorazepam	39	11
Benazepril Hcl	Benazepril Hcl	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	15
Buspirone Hcl	Buspirone Hcl	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	21
Valsartan	Valsartan	35	suppressed
Baclofen	Baclofen	33	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Ipratropium Bromide	Ipratropium Bromide	31	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	24
Ozempic	Semaglutide	29	suppressed
Lovastatin	Lovastatin	28	suppressed
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Acyclovir	Acyclovir	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	14
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Prazosin Hcl	Prazosin Hcl	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	11
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	17
Nitroglycerin	Nitroglycerin	21	17
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Glipizide	Glipizide	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Latanoprost	Latanoprost	18	suppressed
Methadone Hcl	Methadone Hcl	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Nystatin	Nystatin	17	suppressed
Mupirocin	Mupirocin	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Cephalexin	Cephalexin	15	13
Ibuprofen	Ibuprofen	15	suppressed
Primidone	Primidone	15	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Cefdinir	Cefdinir	14	13
Colchicine	Colchicine	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	11
Levetiracetam	Levetiracetam	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Azithromycin	Azithromycin	13	13
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Galantamine Er	Galantamine Hbr	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Bicalutamide	Bicalutamide	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error